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erg) tydens 1(} dae na onttrekking van die middels geeva-
lueer. Die eindevaluasie was die meting wat op die
hoogste getal dae gemaak is, met ander woorde op 5 of
meer dae. Die tydsverloop vanaf die staking van inname
van die middels tot die eerste ontstaan van hierdie
onttrekkingsimptome is ook waargeneem.
Gevolgtrekking en bespreking
Ses van die 15 pasiente wat met oksasepam behandel was,
het wel onttrekkingsimptome getoon, terwyl slegs 2 van die
15 pasiente \vat met chloordiasepoksied behandel was,
onttrekkingsimptome getoon het. Die hoer insidensie van
onttrekkingsimptome met die kortwerkende bensodiase-
piene in vergelyking met die langwerkendes was opvallend,
maar is nie statisties betekenisvol nie. Die onttrekking-
simptome as gevolg van die gebruik van die kortwerkende
middel het gouer na staking van die middel voorgekom.
Hierdie verskil is statisties betekenisvol.
Die kortwerkende bensodiasepiene het nie aktiewe
metaboliete nie, en daar is nie 'n geleidelike afname van
hul farmakologiese en kliniese effekte nie.... Die weIrug
tyd vir farmakodinamiese en farmakokinetiese aanpassing
na skielike staking van gebruik van die middels verklaar
moontlik die opvalIende hoe insidensie van onttrekking-
simptome. Hierdie oenskynlike nadeel van langtermyntoe-
diening van die kortwerkende middels kan waarskynlik
voorkom word deur die dosering geleidelik oor 'n aantal
dae te verminder.
Sommige alkoholiste is fisies afhanklik van beide
alkohol en die bensodiasepiene.- Indien die bensodiase-
piene en alkohol gelyktydig by sulke pasiente onttrek word,
kan die alkohol-onttrekkingsindroom vererger word.
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Combination of radiosensitizers and
hyperthermia in tumour radiotherapy
V.BRLJCKNER
Summary
Specific metabolic properties of hypoxic (and therefore
radio-resistant) tumour cells are responsible for the
selective effect of radiosensitizers (such as misonida-
zole) and hyperthermia upon these cells in respect of
radiosensitization as well as cytotoxicity. Radiosensi-
tizers and hyperthermia should therefore be used to
improve the results of tumour radiotherapy; enhance-
ment ratios of 2 - 4 have already been attained' experi-
mentally with this combined treatmen~. In spite of
these good results. certain problems exist, and up to
now the combination of radiosensitizers and hyperther-
mia has not been used to any great extent for tumours
in humans.
s. Atr. med. J., 59, 116 (1981).
Hypoxic tumour cells are a major problem in radiotherapy
since they are only slightly radiosensitive and therefore
very often the starting point of tumour recurrence.',n The
percentage of hypoxic cells in a tumour depends on its age;
for exper'imental tumours, values of up to 50% are cited."u
For a long time attempts have been made to overcome this
difficulty by bringing about a general increase in tumour
radiosensitivity. Two promising methods are the 'use of
chemical radiosensitizers (especially Inisonidazole) shortly
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before irradiation:,n and induction of local hypertherInili
immediately before or during or immediately after irra-
diation. ',_,lo,n, '0,",'"
The metabolic difference between normal and tumour
cells (Fig. 1) is due to the fact that in cancer cells, and
especially in hypoxic cancer cells, fermentation plays a
greater role than in normal cells.""'z Because of the
related lactic acid production, tumour cells in general and
especially hypoxic tumour cells have a lower pH value
than normal cells.""'" Radiosensitizers and hypertherInia
exercise not only a radiosensitizing effect but also a cyto-
toxic effect (Fig. 2). The radiosensitizing effect affects
hypoxic cells exclusively.'" As regards the cytotoxic effect
of the radiosensitizers·,I',21 as well as the radiosensitizing1<,:zs
and cytotoxic effects",1li·1T,7r of hyperthermia, it was found
experimentally and quite astonishingly that hypoxic cells
are always more sensitive than normoxic cells. This means
that radiosensitizers as well as hypertherInia act selectively
upon hypoxic cells; one reason for this may be their
lowered pH value.-,n, ..,,. Hence not only can radiosensi-
tizers and hyperthermia be used alone but they can also
be combined in radiotherapy in order to increase the
desired effects.
Table I shows early results. The enhancement ratio is
the relationship between a radiation dose for a certain
biological effect and that radiation dose which, with
simultaneous administration of misonidazole and/or
hyperthermia, leads to the same effect. The therapeutic
value of the method is thus in direct proportion to the
enhancement ratio, and the combination of a radiosensi-
tizer such as misonidazole and hypertherInia is always
more effective than either method used alone. Misonida-
zole and hypertherInia are also effective under neutron
irradiation. With misonidazole and hypertherInia, enhance-
mep.t ratios of 2 - 4 have been attained.
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Despite these good experimental results, this combined
treatment has not so far been extensively used for
tumours in human subjects. Possible reasons for this are:
(i) technical difficulties in administering local hyperther-
mia (especially with deep-lying tumours); (iO the risk of
polyneuropathy with misonidazole, which has limited the
dose to 80 mg/kg per fraction with a total not more than
approximately 30 g. '.13 In contrast, in mice 500 - 1 000 mg/
kg have been administered, "-"".20 resulting in greater radio-
sensitization; (iii) the effect of hyperthermia in increasing
the cytotoxicity of misonidazole and at the same time re-
ducing its selectivity for hypoxic cells;" (iv) the effect of
rnisonidazole on temperature regulation;" combined treat-
ment could be either advantageous (raising body tempera-
ture)" or disadvantageous (lowering body temperature);"
this would in either case make it more difficult to produce
optimal results. It is hoped that these difficulties will soon
be overcome, for instance through the jjevelopment of
more suitable hyperthermia apparatus or techniques, or
the synthesis of better radiosensitizers.
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Combustion: C.H"O. + 6 0, ----? 6 Co, + 6 H,O + 686 kcaljmol














Fig. 1. Metabolic difference between nonnal and tumour cells.
FIg. 2. Selective effects of radiosensitizers and hyperthermia on hypoxic ceUs.
Radiosensmzer Hyperthennia
(misonidazole)
Radiosensitizing HYPOXIC CELLS Radiosensitizing
effect (only on Natural occurrence effect (greater
hypoxic cells) ) in .tumours on hypoxic cells)
Cytotoxic effect Radio-resistant Cytotoxic effect
(greater on Low pH value (greater on
hypoxic cells) hypoxic cells)
-
Porschen et al.19•20
Mouse tumour in vivo













(60 min at 42·C, locally)
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TABLE I. ENHANCEMENT RATIOS ATTAINED
Porschen et al.19•20
Weber et alY
Mouse tumour in vivo





















TCDso,IOO = tumour cure dose, i.e. radiation dose which cures/controls 50% of the treated tumours within 100 days.
